CBS 2019
CBSMD教育中心
中 文

药物涂层球囊

Abstract

Recommended Article

Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR Report Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents Survival After Coronary Revascularization With Paclitaxel-Coated Balloons Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis

Original Research2008 Jun;57(6):1702-6.

JOURNAL:Diabetes. Article Link

Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes

Costacou T, Ferrell RE, Orchard TJ. Keywords: T1DM; haptoglobin genotype; haptoglobin 2/2 genotype;

FULL TEXT PDF